Aspire Biopharma Holdings (ASBP) Cash & Current Investments (2022 - 2026)
Aspire Biopharma Holdings' Cash & Current Investments was $12.17 million in Q2 2026, compared with $206,233 a year earlier and up 107.7% from the prior quarter.
Powered by 
Analysis
Aspire Biopharma Holdings (ASBP) Cash & Current Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Aspire Biopharma Holdings came in at $1 million.
- Cash & Current Investments shows a three-year compound annual growth rate of 26.4% (FY2022 to FY2025).
- In earlier years, Cash & Current Investments was $3,633 in FY2024 (-67.5%), $11,174 in FY2023 (-97.8%) and $497,259 in FY2022.
- The Q2 2026 figure marks the highest quarterly Cash & Current Investments in data going back to Q1 2022.
- The best year-over-year quarter for Cash & Current Investments over five years was Q2 2025 (growth of 952.0%); the worst was Q3 2023 (a decline of 99.9%).
- Per Business Quant data, ASBP's Cash & Current Investments in the three quarters before Q2 2026 was $5.86 million (Q1 2026), $1 million (Q4 2025) and $1.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Aspire-Lakewood Holdings | 65.71 Mn | 44.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.17 Mn |
| Mar 31, 2026 | 5.86 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 206,233.00 |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 3,633.00 |
| Sep 30, 2024 | 16,541.00 |
| Jun 30, 2024 | 19,604.00 |
| Mar 31, 2024 | 47,287.00 |
| Dec 31, 2023 | 11,174.00 |
| Sep 30, 2023 | 280.00 |
| Jun 30, 2023 | 125,201.00 |
| Mar 31, 2023 | 315,152.00 |
| Dec 31, 2022 | 497,259.00 |
| Sep 30, 2022 | 533,129.00 |
| Jun 30, 2022 | 579,751.00 |
| Mar 31, 2022 | 618,122.00 |
API Access
Aspire Biopharma Holdings Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ASBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ASBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ASBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();